Task: Answer the multiple choice question.
Query: Which compound exhibits a -19.678% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] Cc1cccc(NC(=O)C2CCN(S(=O)(=O)c3ccc(Cl)cc3)CC2)n1
[b] CCCCN(CC)C(=O)Cn1ncc2c1-c1cc(C)ccc1OC2
[c] Cc1nonc1C(=O)N/N=C/c1cc2c(cc1Br)OCO2
Answer: b. CCCCN(CC)C(=O)Cn1ncc2c1-c1cc(C)ccc1OC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(CC)C(=O)Cn1ncc2c1-c1cc(C)ccc1OC2
CCCCN(CC)C(=O)Cn1ncc2c1-c1cc(C)ccc1OC2
N-butyl-N-ethyl-2-(8-methyl-4H-chromeno[4,3-c]pyrazol-1-yl)acetamide